Cellarity
Year2022
RoundSeries C
Amount$121M
Overall
Summary
12 slides
12 slides
1 slide
Introducing Cellarity, a pioneer in encoding biology to engineer breakthrough medicines.
2 slides
Traditional drug discovery often focuses on individual molecular targets and can overlook the complexities of disease biology at the cellular level.
5 slides
Cellarity employs a transformative cell-centric approach, utilizing high-resolution data and machine learning to uncover unique biological patterns and create therapies with enhanced clinical success rates.
1 slide
Cellarity has gained recognition from leading investors, publications, and industry awards, showcasing its innovative approach and potential impact.
1 slide
Our interdisciplinary team consists of experts from diverse backgrounds, ensuring innovation and the ability to execute our groundbreaking vision.
1 slide
Join us in revolutionizing the future of therapeutic development through our unlimited platform built for clinical success.
